Get started
Author

Sophie Roider‐Schur

Observed names: S Roider-Schur, S. Roider-Schur, Sophie Roider-Schur
ORCID: 0000-0002-3797-0268
Observed ORCID: 0000-0002-3797-0268
OpenAlex ID: A5008248378
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
2022 · Rupert Bartsch, Anna Sophie Berghoff, et al. · Nature Medicine · 413
PDF
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases
2024 · Rupert Bartsch, Anna Sophie Berghoff, et al. · Neuro-Oncology · 81
PDF
Leitlinie zur Palliativen Sedierungstherapie (Langversion): Ergebnisse eines Delphiprozesses der Österreichischen Palliativgesellschaft (OPG)
2016 · Dietmar Weixler, Sophie Roider-Schur, et al. · Wiener Medizinische Wochenschrift · 27
PDF
280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial
2021 · R. Bartsch, A.S. Berghoff, et al. · Annals of Oncology · 22
PDF
165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial
2022 · R. Bartsch, A.S. Berghoff, et al. · Annals of Oncology · 17
Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma—experience at two centres
2020 · Ursula M. Vogl, Laurenz Vormittag, et al. · Journal of Gastrointestinal Oncology · 13
PDF
Migrate your mind: the role of palliative care in transcultural cancer treatment
2019 · Sophie Roider-Schur, Tamara Rumpold, et al. · Wiener klinische Wochenschrift · 6
PDF
Attitude Towards End of Life Communication of Austrian Medical Students
2018 · Tamara Rumpold, Carola Lütgendorf-Caucig, et al. · Journal of Cancer Education · 6
‘It needs experience and courage’: Awareness towards end of life communication practices in oncologists: A mixed methods study
2022 · Tamara Diendorfer, Sophie Roider‐Schur, et al. · European Journal of Cancer Care · 4
PDF
Establishing end-of-life boards for palliative care of patients with advanced diseases
2018 · Eva K. Masel, Matthias Unseld, et al. · Wiener klinische Wochenschrift · 4
PDF
Patients’ attitude and knowledge towards resuscitation and advance care planning at the palliative care unit
2019 · Matthias Unseld, Gloria M. Gager, et al. · European Journal of Cancer Care · 3
PDF
Abstract PO2-04-05: FINAL OUTCOME ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-POSITIVE BREAST CANCER PATIENTS WITH ACTIVE BRAIN METASTASES
2024 · Rupert Bartsch, Anna Sophie Berghoff, et al. · Cancer Research · 2
281MO Quality of life and neurocognitive function in patients with active brain metastases of HER2-positive breast cancer treated with trastuzumab-deruxtecan: Secondary endpoint analysis of the prospective single-arm phase II TUXEDO-1 trial
2022 · A.M. Starzer, A.S.S. Berghoff, et al. · Annals of Oncology · 2
Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction: A case report
2023 · Sophie Roider-Schur, Sybille Machat, et al. · memo - Magazine of European Medical Oncology · 1
Palliative sedation for delirium management at the end of life
2020 · Sophie Roider-Schur · memo - Magazine of European Medical Oncology · 1
Prognostic value of systemic inflammatory biomarkers in advanced gastroesophageal adenocarcinoma patients undergoing chemoimmunotherapy
2026 · Martin Korpan, Daniel Nothdurfter, et al. · Cancer Immunology Immunotherapy
Therapeutic management of resectable mismatch-repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: a real-world analysis from Austria
2026 · Martin Korpan, Daniel Nothdurfter, et al. · Gastric Cancer
PDF
579P Therapeutic management of resectable mismatch repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: A multicenter retrospective real-world analysis from Austria
2026 · M. Korpan, D. Nothdurfter, et al. · Annals of Oncology
PDF
OS01.5.A Neuron-specific enolase (NSE) and S100 serum levels in patients with active brain metastases from HER2-positive breast cancer treated with trastuzumab-deruxtecan (T-DXd): A biomarker analysis from the TUXEDO-1 trial
2022 · A S Berghoff, R Bartsch, et al. · Neuro-Oncology
PDF
Soft tissue sarcomas & GIST: Highlights from ASCO meeting 2016
2016 · Sophie Roider-Schur, Rainer Hamacher, et al. · memo - Magazine of European Medical Oncology
PDF
Works count: 20
Citation count: 602
H-index: 6
I10-index: 6
Year
Topic
Type